Literature DB >> 23194035

Hospitalizations for cardiovascular disease in African Americans and whites with HIV/AIDS.

Christine U Oramasionwu1, Gene D Morse, Kenneth A Lawson, Carolyn M Brown, Jim M Koeller, Christopher R Frei.   

Abstract

Therapeutic advances have resulted in an epidemiological shift in the predominant causes of hospitalization for patients with HIV/AIDS. An emerging cause for hospitalization in this patient population is cardiovascular disease (CVD); however, data are limited regarding how this shift affects different racial groups. The objective of this observational, retrospective study was to evaluate the association between race and hospitalization for CVD in African Americans and whites with HIV/AIDS and to compare the types of CVD-related hospitalizations between African Americans and whites with HIV/AIDS. Approximately 1.5 million hospital discharges from the US National Hospital Discharge Surveys for the years of 1996 to 2008 were identified. After controlling for potential confounders, the odds of CVD-related hospitalization in patients with HIV/AIDS were 45% higher for African Americans than whites (odds ratio [OR]=1.45, 95% CI, 1.39-1.51). Other covariates that were associated with increased odds of hospitalization for CVD included chronic kidney disease (OR=1.43, 95% CI, 1.36-1.51), age≥50 years (OR=3.22, 95% CI, 2.94-3.54), region in the Southern United States (OR=1.17, 95% CI, 1.11-1.23), and Medicare insurance coverage (OR=1.71, 95% CI, 1.60-1.83). Male sex was not significantly associated with the study outcome (OR=0.99, 95% CI, 0.96-1.02). Compared to whites with HIV/AIDS, African Americans with HIV/AIDS had more hospitalizations for heart failure and hypertension, but fewer hospitalizations for stroke and coronary heart disease. In conclusion, African Americans with HIV/AIDS have increased odds of CVD-related hospitalization as compared to whites with HIV/AIDS. Furthermore, the most common types of CVD-related hospitalizations differ significantly in African Americans and whites.

Entities:  

Mesh:

Year:  2012        PMID: 23194035      PMCID: PMC3840471          DOI: 10.1089/pop.2012.0043

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  24 in total

1.  Design and operation of the National Hospital Discharge Survey: 1988 redesign.

Authors:  C Dennison; R Pokras
Journal:  Vital Health Stat 1       Date:  2000-12

2.  Race differences in access to health care and disparities in incident chronic kidney disease in the US.

Authors:  Kira Evans; Josef Coresh; Lori D Bash; Tiffany Gary-Webb; Anna Köttgen; Kathryn Carson; L Ebony Boulware
Journal:  Nephrol Dial Transplant       Date:  2010-08-05       Impact factor: 5.992

3.  Sudden cardiac death in the United States, 1989 to 1998.

Authors:  Z J Zheng; J B Croft; W H Giles; G A Mensah
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

4.  Racial disparities in hypertension prevalence, awareness, and management.

Authors:  Robin P Hertz; Alan N Unger; Jeffrey A Cornell; Elijah Saunders
Journal:  Arch Intern Med       Date:  2005-10-10

5.  Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.

Authors:  Kelly A Gebo; John A Fleishman; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

6.  Differences in national antiretroviral prescribing patterns between black and white patients with HIV/AIDS, 1996-2006.

Authors:  Christine U Oramasionwu; Carolyn M Brown; Kenneth A Lawson; Laurajo Ryan; Jeff Skinner; Christopher R Frei
Journal:  South Med J       Date:  2011-12       Impact factor: 0.954

7.  Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic.

Authors:  Christopher S Krawczyk; Ellen Funkhouser; J Michael Kilby; Richard A Kaslow; Amita K Bey; Sten H Vermund
Journal:  South Med J       Date:  2006-05       Impact factor: 0.954

8.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Authors:  Virginia A Triant; Hang Lee; Colleen Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

9.  Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.

Authors:  Suying Li; Donna D McAlpine; Jiannong Liu; Shuling Li; Allan J Collins
Journal:  Adv Ren Replace Ther       Date:  2004-01

10.  Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.

Authors:  Lytt I Gardner; Robert S Klein; Lynda A Szczech; Ruby M Phelps; Karen Tashima; Anne M Rompalo; Paula Schuman; Ramses F Sadek; Tony C Tong; Alan Greenberg; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2003-11-01       Impact factor: 3.731

View more
  3 in total

1.  HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction.

Authors:  Anne-Lise Paisible; Chung-Chou H Chang; Kaku A So-Armah; Adeel A Butt; David A Leaf; Matthew Budoff; David Rimland; Roger Bedimo; Matthew B Goetz; Maria C Rodriguez-Barradas; Heidi M Crane; Cynthia L Gibert; Sheldon T Brown; Hilary A Tindle; Alberta L Warner; Charles Alcorn; Melissa Skanderson; Amy C Justice; Matthew S Freiberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

Review 2.  Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.

Authors:  Charles Muiruri; Chris T Longenecker; Eric G Meissner; Nwora Lance Okeke; April C Pettit; Kevin Thomas; Eric Velazquez; Gerald S Bloomfield
Journal:  Prog Cardiovasc Dis       Date:  2020-02-11       Impact factor: 8.194

3.  Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).

Authors:  Aditi Shendre; Howard W Wiener; Marguerite R Irvin; Bradley E Aouizerat; Edgar T Overton; Jason Lazar; Chenglong Liu; Howard N Hodis; Nita A Limdi; Kathleen M Weber; Stephen J Gange; Degui Zhi; Michelle A Floris-Moore; Ighovwerha Ofotokun; Qibin Qi; David B Hanna; Robert C Kaplan; Sadeep Shrestha
Journal:  PLoS One       Date:  2017-12-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.